Forman, D. et al. (eds) Cancer Incidence in Five Continents Volume X (IARC, 2014).
Rudin, C. M. et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat. Rev. Cancer 19, 289–297 (2019).
Article CAS PubMed PubMed Central Google Scholar
Gay, C. M. et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39, 346–360 (2021).
Article CAS PubMed PubMed Central Google Scholar
Burr, M. L. et al. An evolutionarily conserved function of Polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell 36, 385–401 (2019).
Article CAS PubMed PubMed Central Google Scholar
Mahadevan, N. R. et al. Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity. Cancer Discov. 11, 1952–1969 (2021).
Article CAS PubMed PubMed Central Google Scholar
Chan, J. M. et al. Signatures of plasticity, metastasis and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 39, 1479–1496 (2021).
Article CAS PubMed PubMed Central Google Scholar
Huynh, J., Chand, A., Gough, D. & Ernst, M. Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map. Nat. Rev. Cancer 19, 82–96 (2019).
Article CAS PubMed Google Scholar
Hong, D. et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci. Transl. Med. 7, 314ra185 (2015).
Article PubMed PubMed Central Google Scholar
George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47–53 (2015).
Article CAS PubMed PubMed Central Google Scholar
Azare, J. et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin β6. Mol. Cell. Biol. 27, 4444–4453 (2007).
Article CAS PubMed PubMed Central Google Scholar
Mollaoglu, G. et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition. Cancer Cell 31, 270–285 (2017).
Article CAS PubMed PubMed Central Google Scholar
Chen, J. et al. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. Oncogene 41, 138–145 (2022).
Article CAS PubMed Google Scholar
Travis, W. D. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod. Pathol. 25, S18–S30 (2012).
Article CAS PubMed Google Scholar
Nakazawa, K. et al. Specific organ metastases and survival in small cell lung cancer. Oncol. Lett. 4, 617–620 (2012).
Article PubMed PubMed Central Google Scholar
Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328–342 (2016).
Article CAS PubMed PubMed Central Google Scholar
Huntington, N. D., Cursons, J. & Rautela, J. The cancer–natural killer cell immunity cycle. Nat. Rev. Cancer 20, 437–454 (2020).
Article CAS PubMed Google Scholar
Raz, R., Durbin, J. E. & Levy, D. E. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons and growth factors. J. Biol. Chem. 269, 24391–24395 (1994).
Article CAS PubMed Google Scholar
Musella, M., Manic, G., De Maria, R., Vitale, I. & Sistigu, A. Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications. Oncoimmunology 6, e1314424 (2017).
Article PubMed PubMed Central Google Scholar
Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6, 722–729 (2005).
Article CAS PubMed Google Scholar
Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).
Article CAS PubMed PubMed Central Google Scholar
Yu, C. H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell 183, 636–649 (2020).
Article CAS PubMed PubMed Central Google Scholar
Sen, T. et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov. 9, 646–661 (2019).
Article CAS PubMed PubMed Central Google Scholar
Rusinova, I. et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040–D1046 (2013).
Article CAS PubMed Google Scholar
Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224–1231 (2012).
Article CAS PubMed Google Scholar
Zhao, Y. et al. Overexpression of interferon regulatory factor 7 (IRF7) reduces bone metastasis of prostate cancer cells in mice. Oncol. Res 25, 511–522 (2017).
Article PubMed PubMed Central Google Scholar
Gough, D. J. et al. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324, 1713–1716 (2009).
Article CAS PubMed PubMed Central Google Scholar
Grabner, B. et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat. Commun. 6, 6285 (2015).
Article CAS PubMed Google Scholar
Lee, C.-K. et al. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165, 3571 (2000).
Article CAS PubMed Google Scholar
Best, S. A. et al. Harnessing natural killer immunity in metastatic SCLC. J. Thorac. Oncol. 15, 1507–1521 (2020).
Article CAS PubMed Google Scholar
Glasner, A. et al. NKp46 receptor-mediated interferon-γ production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity 48, 107–119 (2018).
Article CAS PubMed Google Scholar
van der Weyden, L. et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature 541, 233–236 (2017).
留言 (0)